Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-02-22 02:06 | 2019-02-19 | TCRR | N/A | UBS Oncology Impact Fund L.P. | 10% owner | Other | BUY | $15.00 | 666,667 | $10,000,005 | 3,370,982 | +24.7% |
| 2019-02-22 01:01 | 2019-02-19 | TCRR | N/A | Jovan-Embiricos Morana | Director, 10% owner | Other | BUY | $15.00 | 666,667 | $10,000,005 | 536,962 | +100.0% |
| 2019-02-22 00:54 | 2019-02-19 | TCRR | N/A | Upnorth Investment Ltd | 10% owner | Other | BUY | $15.00 | 200,000 | $3,000,000 | 2,137,419 | +10.3% |
| 2019-02-22 00:18 | 2019-02-19 | XERS | N/A | Redmile Group, LLC | 10% owner | Other | BUY | $10.00 | 588,000 | $5,880,000 | 3,000,642 | +24.4% |
| 2019-02-22 02:05 | 2019-02-19 | TCRR | N/A | MPM BioVentures 2014, L.P. | 10% owner | Other | BUY | $15.00 | 706,666 | $10,599,990 | 4,050,865 | +21.1% |
| 2019-02-22 00:52 | 2019-02-19 | TCRR | N/A | GADICKE ANSBERT | Director, 10% owner | Other | BUY | $15.00 | 1,373,333 | $20,599,995 | 1,569,235 | +701.0% |
| 2019-02-21 00:08 | 2019-02-15 | N/A | N/A | Moneda Carlyle XI Fondo de Inversion | 10% owner | Other | BUY | $20.87 | 148,879 | $3,107,105 | 1,492,362 | +11.1% |
| 2019-02-21 00:03 | 2019-02-15 | N/A | N/A | Fresno County Employees' Retirement Association | 10% owner | Other | BUY | $20.87 | 204,879 | $4,275,825 | 2,123,188 | +10.7% |
| 2019-02-21 00:39 | 2019-02-15 | IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Winder Investment Pte Ltd | 10% owner | Industrial Organic Chemicals | BUY | $134.01 | 114,000 | $15,276,832 | 20,180,358 | +0.6% |
| 2019-02-20 00:56 | 2019-02-14 | IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Winder Investment Pte Ltd | 10% owner | Industrial Organic Chemicals | BUY | $132.28 | 85,946 | $11,368,928 | 20,066,358 | +0.4% |
| 2019-02-20 05:04 | 2019-02-19 | QSR | Restaurant Brands International Inc. | MACEDO ALEXANDRE | Officer - President,Tim Hortons | Retail-Eating Places | BUY | $64.73 | 45,000 | $2,912,850 | 186,134 | +31.9% |
| 2019-02-20 04:00 | 2019-01-04 | OXBR | OXBRIDGE RE HOLDINGS Ltd | MARTIN ALLAN S. | 10% owner | Fire, Marine & Casualty Insurance | BUY | $17.26 | 120,919 | $2,087,243 | 51,098 | +100.0% |
| 2019-02-20 01:05 | 2019-02-14 | GNCA | N/A | Sonsini Peter W. | 10% owner | Other | BUY | $0.47 | 9,948,269 | $4,688,619 | 34,948,269 | +39.8% |
| 2019-02-20 01:03 | 2019-02-14 | GNCA | N/A | Makhzoumi Mohamad | 10% owner | Other | BUY | $0.47 | 9,948,269 | $4,688,619 | 34,948,269 | +39.8% |
| 2019-02-20 01:02 | 2019-02-14 | GNCA | N/A | Florence Anthony A. Jr. | 10% owner | Other | BUY | $0.47 | 9,948,269 | $4,688,619 | 34,948,269 | +39.8% |
| 2019-02-20 01:02 | 2019-02-14 | GNCA | N/A | Chang Carmen | 10% owner | Other | BUY | $0.47 | 9,948,269 | $4,688,619 | 34,948,269 | +39.8% |
| 2019-02-20 01:02 | 2019-02-14 | GNCA | N/A | Behbahani Ali | Director, 10% owner | Other | BUY | $0.47 | 9,948,269 | $4,688,619 | 34,948,269 | +39.8% |
| 2019-02-20 01:00 | 2019-02-14 | GNCA | N/A | New Enterprise Associates 16, L.P. | 10% owner | Other | BUY | $0.47 | 9,948,269 | $4,688,619 | 34,948,269 | +39.8% |
| 2019-02-20 03:12 | 2019-02-19 | AVDR | N/A | Kong Garheng | Director | Other | BUY | $14.00 | 142,857 | $1,999,998 | 1,437,096 | +11.0% |
| 2019-02-20 01:01 | 2019-02-14 | GNCA | N/A | BASKETT FOREST | 10% owner | Other | BUY | $0.47 | 9,948,269 | $4,688,619 | 34,948,269 | +39.8% |
| 2019-02-20 01:04 | 2019-02-14 | GNCA | N/A | SANDELL SCOTT D | 10% owner | Other | BUY | $0.47 | 9,948,269 | $4,688,619 | 34,948,269 | +39.8% |
| 2019-02-20 01:03 | 2019-02-14 | GNCA | N/A | MAKOWER JOSHUA | 10% owner | Other | BUY | $0.47 | 9,948,269 | $4,688,619 | 34,948,269 | +39.8% |
| 2019-02-20 01:04 | 2019-02-14 | GNCA | N/A | MOTT DAVID M | 10% owner | Other | BUY | $0.47 | 9,948,269 | $4,688,619 | 34,948,269 | +39.8% |
| 2019-02-19 17:16 | 2019-02-15 | KMI | KINDER MORGAN, INC. | KINDER RICHARD D | Director, Officer, 10% owner - Executive Chairman | Natural Gas Transmission | BUY | $18.93 | 200,000 | $3,785,680 | 236,692,545 | +0.1% |
| 2019-02-20 01:00 | 2019-02-14 | GNCA | N/A | BARRIS PETER J | 10% owner | Other | BUY | $0.47 | 9,948,269 | $4,688,619 | 34,948,269 | +39.8% |
| 2019-02-15 17:27 | 2019-02-14 | VTVT | vTv Therapeutics Inc. | PERELMAN RONALD O | 10% owner | Pharmaceutical Preparations | BUY | $1.84 | 815,217 | $1,499,999 | 15,678,436 | +5.5% |
| 2019-02-15 01:24 | 2019-02-12 | HARP | N/A | Chin Mark | Director, 10% owner | Other | BUY | $14.00 | 428,571 | $5,999,994 | 2,892,119 | +17.4% |
| 2019-02-15 02:01 | 2019-02-12 | HARP | N/A | Arix Bioscience plc | 10% owner | Other | BUY | $14.00 | 428,571 | $5,999,994 | 2,892,119 | +17.4% |
| 2019-02-15 01:34 | 2019-02-12 | HARP | N/A | UBS Oncology Impact Fund L.P. | 10% owner | Other | BUY | $14.00 | 250,000 | $3,500,000 | 3,898,422 | +6.9% |
| 2019-02-15 01:33 | 2019-02-12 | HARP | N/A | New Leaf Ventures III, L.P. | 10% owner | Other | BUY | $14.00 | 428,571 | $5,999,994 | 678,566 | +171.4% |
| 2019-02-15 00:41 | 2019-02-12 | N/A | Blue Owl Capital Corp | Ostrover Douglas I | Director | Other | BUY | $15.40 | 534,164 | $8,226,126 | 1,114,236 | +92.1% |
| 2019-02-15 01:32 | 2019-02-12 | HARP | N/A | MPM BioVentures 2014, L.P. | 10% owner | Other | BUY | $14.00 | 250,000 | $3,500,000 | 4,524,425 | +5.8% |
| 2019-02-15 01:30 | 2019-02-12 | HARP | N/A | HUNT RONALD | Director, 10% owner | Other | BUY | $14.00 | 428,571 | $5,999,994 | 678,566 | +171.4% |
| 2019-02-15 01:19 | 2019-02-12 | HARP | N/A | EVNIN LUKE | Director, 10% owner | Other | BUY | $14.00 | 250,000 | $3,500,000 | 4,524,425 | +5.8% |
| 2019-02-15 01:28 | 2019-02-12 | HARP | N/A | GADICKE ANSBERT | 10% owner | Other | BUY | $14.00 | 500,000 | $7,000,000 | 8,422,847 | +6.3% |
| 2019-02-14 22:38 | 2018-12-21 | XBIT | XBiotech Inc. | RENNES FONDATION | 10% owner | Pharmaceutical Preparations | BUY | $9.25 | 112,300 | $1,039,045 | 3,698,282 | +3.1% |
| 2019-02-15 00:34 | 2019-02-12 | CORT | CORCEPT THERAPEUTICS INC | BAKER G LEONARD JR | Director | Pharmaceutical Preparations | BUY | $11.39 | 100,000 | $1,138,710 | 3,114,793 | +3.3% |
| 2019-02-14 20:04 | 2019-02-13 | GNTY | N/A | Baker Richard W. | Director | Other | BUY | $30.00 | 100,000 | $3,000,000 | 470,000 | +27.0% |
| 2019-02-15 02:25 | 2019-02-01 | NHLD | N/A | ASHER DANIEL | 10% owner | Other | BUY | $3.25 | 878,932 | $2,856,529 | 2,464,806 | +55.4% |
| 2019-02-13 21:38 | 2019-02-07 | KALO | N/A | Kassett Rajni | 10% owner | Other | BUY | $149,240.20 | 3,731,005 | $556,815,932,401 | 23,698,279 | +18.7% |
| 2019-02-14 01:10 | 2018-10-15 | ALLO | Allogene Therapeutics Inc. | Belldegrun Arie | Director | Biological Products, (No Diagnostic Substances) | BUY | $18.00 | 194,445 | $3,500,010 | 1,691,781 | +13.0% |
| 2019-02-13 00:05 | 2019-02-08 | EVFM | Evofem Biosciences, Inc. | Invesco Ltd. | 10% owner | Pharmaceutical Preparations | BUY | $2.64 | 425,531 | $1,123,402 | 9,590,688 | +4.6% |
| 2019-02-13 04:42 | 2017-12-27 | KALO | N/A | Kassett Rajni | 10% owner | Other | BUY | $11,980.00 | 1,996,667 | $23,920,070,660 | 19,963,941 | +11.1% |
| 2019-02-13 01:08 | 2015-11-27 | KALO | N/A | Kassett Rajni | 10% owner | Other | BUY | $56,134.50 | 474,337,466 | $26,626,694,113,490 | 1,180,364,472 | +67.2% |
| 2019-02-12 23:56 | 2015-06-05 | KALO | N/A | Kassett Rajni | 10% owner | Other | BUY | $30,351.84 | 611,157,491 | $18,549,755,176,138 | 706,027,006 | +644.2% |
| 2019-02-13 01:23 | 2019-02-08 | OCX | Insight Molecular Diagnostics Inc. | BROADWOOD PARTNERS, L.P. | 10% owner | In Vitro & In Vivo Diagnostic Substances | BUY | $3.75 | 533,333 | $1,999,999 | 8,098,267 | +7.1% |
| 2019-02-13 00:45 | 2019-02-08 | MB | N/A | Luxor Capital Group, LP | 10% owner | Other | BUY | $36.46 | 802,075 | $29,246,863 | 1,543,299 | +108.2% |
| 2019-02-13 01:05 | 2019-02-08 | POST | Post Holdings, Inc. | STIRITZ WILLIAM P | Director | Grain Mill Products | BUY | $97.75 | 35,755 | $3,495,069 | 2,695,617 | +1.3% |
| 2019-02-13 01:33 | 2019-02-12 | KMI | KINDER MORGAN, INC. | KINDER RICHARD D | Director, Officer, 10% owner - Executive Chairman | Natural Gas Transmission | BUY | $18.39 | 200,000 | $3,678,860 | 236,492,545 | +0.1% |
| 2019-02-11 18:31 | 2019-02-06 | NHS | Neuberger High Yield Strategies Fund Inc. | Saba Capital Management, L.P. | 10% owner | Other | BUY | $10.92 | 97,379 | $1,063,018 | 3,179,202 | +3.2% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.